comparemela.com

Latest Breaking News On - Selexis - Page 1 : comparemela.com

JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc and Selexis SA to Operate as one Organization, Providing Seamless Experience for Partners

KBI's new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers JSR Life Sciences today announced that KBI Biopharma, Inc.

United statesTim loweryCrown bioscienceBlair cieckoLife scienceBiopharma incLife sciencesCompany inquiriesChief executive officerMedia inquiries

Selexis SA and NexImmune Inc : Selexis and NexImmune Sign Service Agreement to Advance Multiple Immunotherapies Targeting Rare Cancers and Autoimmune Disorders

Agreement supports the development of molecules targeting acute myeloid leukemia, multiple myeloma, human papilloma virus (HPV) associated tumors, and additional human leukocyte antigens (HLAs) that

Maria pilar gimMathias oelkeMarkw womackMike beyerCompany inquiries for selexisNeximmune incLife sciencesSam brown incChief executive officerNeximmune chief scientific officerArtificial immune modulationPilar gimMarketing director

KBI Biopharma SA: KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland

The KBI and Selexis co-location will expand biopharmaceutical development and manufacturing capabilities to serve the global demand for novel therapies. KBI Biopharma SA (KBI) and Selexis SA, both

United statesPlan les ouatesLuca bolligerMark lutgenBlair cieckoKostenloser wertpapierhandelTim loweryMarkw womackAruna morMike beyerFabienne fischerMario rodriguezMaria pilar gimenezSelexis sa company inquiriesBiopharma company inquiriesSam brown inc

KBI Biopharma SA and Selexis SA Expand in Europe by Opening an Integrated Biologics Manufacturing Facility in Geneva, Switzerland

KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, announced today that an expanded, fully-integrated mammalian contract development and manufacturing services facility is now open

United statesKostenloser wertpapierhandelAruna morMarkw womackBlair cieckoBiopharma incBiopharma company inquiriesLife sciencesChief executive officerUlrich valleySenior vice presidentOperations site headCompany inquiriesMedia contact

Selexis SA: Great Place to Work Designates Selexis as a Best Workplace in Switzerland for Fifth Straight Year

Selexis SA, a JSR Life Sciences Company, announced today that Great Place to Work has designated the Company among the "Best Workplaces Switzerland" in 2022. Selexis joins organizations across a broad

Michael hermannKostenloser wertpapierhandelRegine brokampRobert meisterMike beyerXlife sciences companySam brown incCompany inquiries for selexisCorporate communicationsLife sciencesSciences companyGreat placeChief operating officerCulture auditWork switzerland

vimarsana © 2020. All Rights Reserved.